Sino Biopharmaceutical to acquire LaNova Medicines for up to $951 million - Reuters

Reuters | July 15, 2025, 11:16 a.m. | Original
Sino Biopharmaceutical to acquire LaNova Medicines for up to $951 million Reuters
US nuclear regulator asks job seekers political questions - Reuters Tesla's top North American sales executive leaves, WSJ reports - Reuters